Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation.
Shady Adnan-AwadOscar BrückNaranie ShanmuganathanTimo JarvinenHanna LähteenmäkiJay KlievinkHazem IbrahimSoili KytöläPerttu KoskenvesaTimothy P HughesSusan BranfordMatti KankainenMohamed El MissiryPublished in: Blood cancer journal (2022)